APA (7th ed.) Citation

E, M., R, F., G, L., G, M., G, P., N, V., . . . SAM, U. (2025). Increased Lyso-Gb1 Levels in an Obese Splenectomized Gaucher Disease Type 1 Patient Treated with Eliglustat: Unacknowledged Poor Compliance or Underlying Factors. Metabolites, 15(7), . https://doi.org/10.3390/metabo15070427

Chicago Style (17th ed.) Citation

E, Maines, Franceschi R, Luppi G, Marchi G, Piccoli G, Vitturi N, Soffiati M, Campomori A, and Urru SAM. "Increased Lyso-Gb1 Levels in an Obese Splenectomized Gaucher Disease Type 1 Patient Treated with Eliglustat: Unacknowledged Poor Compliance or Underlying Factors." Metabolites 15, no. 7 (2025). https://doi.org/10.3390/metabo15070427.

MLA (9th ed.) Citation

E, Maines, et al. "Increased Lyso-Gb1 Levels in an Obese Splenectomized Gaucher Disease Type 1 Patient Treated with Eliglustat: Unacknowledged Poor Compliance or Underlying Factors." Metabolites, vol. 15, no. 7, 2025, https://doi.org/10.3390/metabo15070427.